Behind the Creative: Creative Impact on Brand Success
Darrell Wakefield, Franchise Head, Solid Tumor, Sanofi Genzyme, talks creative impact on brand success.
16m May 25, 2021
16m
Announcing Our 2021 Emerging Pharma Leaders
Since 2008, Pharmaceutical Executive has recognized a class of biopharma professionals to receive the title Emerging Pharma Leader. This year, along with their profiles in our May issue, our editorial team presents a webcast featuring the winners and their up-and-coming perspectives on a range of industry topics. Get a full list of our #2021EPL and read their profiles here:https://www.pharmexe...
34m May 21, 2021
34m
Episode 82: Integrating Sustainability Into Biopharma Strategy
Sandor Schoichet, an independent advisor, and director of Meridian Management Consultants based in San Francisco, and Pharm Exec’s Sustainability columnist, and his co-collaborator, Thomas Scheiwiller, an independent advisor and board member based in Zurich, discuss many of the topics we touch on today in regard to biopharma’s approach to integrating environmental, social, and governance, or ES...
20m May 13, 2021
20m
Behind the Creative: Inspiring Award-Winning Creative
Shaheed Peera, President, Founder and CEO of The Creative Floor Awards, London, and Global Creative Lead for Reckitt Benckiser ECom, talks about inspiring award-winning creative, reflects on his time as President on Cannes, and provides some insight on his award show The Creative Floor as well as a few tips about the inaugural PharmExec APEX Awards Submit your PE APEX nominations here: https:/...
40m May 03, 2021
40m
Episode 81: Cancer Research Amid COVID
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.
17m Apr 29, 2021
17m
Episode 80: Rugby Rules in Pharma
John Furey, CEO of Imvax and an Editorial Advisory Board member for Pharm Exec, discusses some leadership principles he learned while playing rugby as a young man in Ireland, and how those tenets can translate to the C-suite.
15m Apr 15, 2021
15m
Episode 79: Managing Quarantine Remotely
Uche Iloeje, Vice President medical affairs Mirdametenib at SpringWorks Therapeutics, shares his experience after he became stranded in Nigeria for five months and the valuable leadership lessons he learned.
18m Apr 01, 2021
18m
Episode 78: The Digital Denouement of COVID
Paul Shawah, Executive Vice President of Strategy at Veeva Systems, looks back at the past year of the pandemic to see the digital transformation of pharma’s interaction with healthcare professionals.
14m Mar 18, 2021
14m
Episode 77: The Effects of AI on IP
Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.
14m Mar 04, 2021
14m
Episode 76: Repatriating Pharma
Joel Marcus, founder and executive chairman of Alexandria Real Estate Equities, and founder and CEO of Alexandria Venture Investments, discusses the drive to bring pharma manufacturing back to a company’s home country and the issues involved in doing so.
15m Feb 18, 2021
15m
Episode 75: Protecting Pharma Through Cybersecurity
Scott Nawrocki, managing director of digital investigations and cyber defense at Nardello & Co., discusses cybersecurity in pharma, including topics from prevention to crisis management.
33m Feb 04, 2021
33m
Episode 74: 2021 Industry Outlook
Editorial Director, Lisa Henderson; European and online editor, Julian Upton; Senior Editor, Elaine Quilici ;and Assistant Editors of Pharmaceutical Executive, Miranda Schmalfuhs and Andy Studna, discuss some exciting industry trends for 2021, which they recently wrote for the January issue.
25m Jan 21, 2021
25m
Episode 73: Biotech’s IPO Steamroll
Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of industry IPOs might look like
11m Jan 07, 2021
11m
Episode 72: Trying to Outpace Rare Disease
Rich Horgan, founder and president of Cure Rare Disease(CRD), discusses how he sprang into action when his brother was diagnosed with Duchenne muscular dystrophy, by starting a nonprofit biotech to help find a cure.
22m Dec 24, 2020
22m
Episode 71: Connecting With NPs and PAs
Sacha Ward, chief client officer of Point of Care Network, discusses how COVID has affected the roles of nurse practitioners and physician assistants, and why marketing managers should take a moment to understand this growing group of health care influencers.
13m Dec 10, 2020
13m
Episode 70: Keeping Pharma Informed
Krystle Buntemeyer, president of SCORR Marketing, and Bharat Mehta, co-founder of PharmaCompass, discuss a new, free online tool called Pipeline Prospector, which they recently launched in collaboration. The tool aims to provide pharma executives with industry data, including deal and pipeline information, to help them make more informed decisions.
13m Nov 26, 2020
13m
Episode 69: Fighting Influenza During COVID
Dr. Gregg Sylvester, chief medical officer of Seqirus, discusses the importance of vaccinating against the seasonal flu amid the COVID pandemic, and how the two viruses should be considered in light of each other.
9m Nov 12, 2020
9m
Episode 68: Rocking Garage Biotech
Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of pharma, including innovation and pricing.
23m Oct 29, 2020
23m
Episode 67: Succeeding Through Adversity
Sanjeev Luther, president and CEO of Rafael Pharmaceuticals, discusses how he managed to turn around a company on the brink of bankruptcy and advance clinical trials for its lead cancer drug through COVID-19.
11m Oct 15, 2020
11m
Episode 66: New Approach to Antithrombotics
Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attacking blood clots from a new angle and are giving patients new hope.
18m Oct 01, 2020
18m
Episode 65: Creating a Path for Innovation
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.
15m Sep 17, 2020
15m
Episode 64: The Complexities of Managing ADHD
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
16m Sep 03, 2020
16m
Episode 63: Three Simple Principles to Improve Leadership
Eric Turbiville, author of the recently published book “The Perfect Leadership Triad: How Top Executives Maximize Productivity through People, Coaching, and Performance," a 25-year pharma veteran, credentialed executive coach, and director of mentoring for the Southwest region of the Healthcare Businesswomen’s Association says there are three leadership principles can help executives through tu...
17m Aug 20, 2020
17m
Episode 62: The Future of Pharma’s Supply Chain
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.
19m Aug 06, 2020
19m
Episode 61: Preparing for Virtual High-Stakes Meetings
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.
17m Jul 23, 2020
17m
Episode 60: Leading With Compassion
Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing the Chicago location of the company through COVID-19, in light of the fact that he himself is immunocompromised.
14m Jul 09, 2020
14m
Episode 59: Using Tau to Target Alzheimer’s
Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.
16m Jun 25, 2020
16m
Episode 58: Understanding FDA’s Gene Therapy Guidelines
Dr. Jonathan Gertler, CEO of Back Bay Life Science Advisors, and Dr. Stephan Gauldie, Managing Director of Back Bay, talk about the new guidelines set forth by FDA in regard to gene therapy, and what those new parameters mean for pharma and biotech.
19m Jun 11, 2020
19m
Episode 57: Planning for Pharma’s New Normal
Pratap Khedkar, managing principal of ZS Associates, talks about pharma’s scenario planning amid COVID-19 as it looks to settle into a new normal.
18m May 28, 2020
18m
Episode 56: Killing Cancer Through Direct Injection
Lew Bender, founder of Intensity Therapeutics and the inventor of Intensity’s DfuseRx platform technology, discusses the technology that allows the company’s therapeutic products to be injected directly into solid tumors, this innovative process successfully kills tumors and activates an immune response to shut down cancer cells throughout the body.
18m May 14, 2020
18m
Episode 55: Developing a Maternal RSV Vaccine
Kathrin Jansen, Senior Vice President and Head of Vaccine Research and Development at Pfizer, talks about the challenges of creating a new maternal vaccine for respiratory syncytial virus, also known as RSV, currently being administered to pregnant women in trials, in the hopes of protecting their infants.
18m Apr 30, 2020
18m
Episode 54: Taking Advantage of Digital Marketing
Chris Paquette, DeepIntent co-founder and CEO, talks about the evolution of digital marketing in pharma, specifically, how to approach data and technology usage in a privacy-first world.
15m Apr 15, 2020
15m
Episode 53: Fabulous Pharma Females
Barbara Ryan, founder of Barbara Ryan Advisors, a member of PharmExec’s editorial advisory board, and the founder of Fabulous Pharma Females discusses the strong community she’s built providing women the opportunity to connect with each other and reinforce their shared commitment to one another.
17m Apr 02, 2020
17m
Episode 52: Cannabinoids
Yuval Cohen, CEO of Corbus Pharmaceuticals, talks about cannabinoids, the differences between natural and synthetic products, and how biotechs and pharma are using them to treat disease today.
16m Mar 19, 2020
16m
Episode 51: Combating Coronavirus
Dr. Eric von Hofe, Chief Scientific Officer at NuGenerex Immuno-Oncology talks about the recent outbreak of Wuhan coronavirus around the world and how biotechs and pharma are jumping in to help find a solution.
15m Mar 05, 2020
15m
Episode 50: Pharma Pricing Climate in Washington
Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, the challenges he encounters, and what he believes needs to change in the industry going forward.
20m Feb 20, 2020
20m
Episode 49: Navigate Emerging Markets with Data Science
Pharm Exec speaks with Nigel Breakwell and Ben Randal, co-founders of Dot I/O Health. Nigel and Ben talk about how they’re using data science in the health and life sciences industries to help clients navigate emerging markets.
24m Feb 06, 2020
24m
Episode 48: 2020 Industry Outlook
Pharm Exec editors discuss the themes chosen for the January issue focusing on industry trends for the coming year.
21m Jan 23, 2020
21m
Episode 47: Identifying Adherence Issues
Heather Monte, Director of Operations for DirectRx, talks about the specialty pharma’s new Patient Scorecard, which aims to identify and improve adherence by reporting patients’ prescription patterns to doctors.
10m Jan 09, 2020
10m
Episode 46: Persistence and Planning Pays Off
Julia Owens, co-founder and CEO of Millendo Therapeutics talks about how to keep a company on the path to success, even when there are bumps in the road. She discusses the value of focusing on strengths and how that is currently working for Millendo in the endocrine space.
14m Dec 19, 2019
14m
Episode 45: Getting Drug Approval Through FDA LPAD
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs, some ideas that he spoke about on the recent NORD panel about innovative and ethical partnerships, and Insmed’s pipeline and progress.
27m Dec 05, 2019
27m
Episode 44: Annual Pipeline Report
Pharm Exec editors discuss the articles they focused on for the November Annual Pipeline Report.
19m Nov 21, 2019
19m
Episode 43: Pharma Reputation
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
23m Nov 07, 2019
23m
Episode 42: Establishing a New Drug Therapy
Pharm Exec editors interview Mark Glickman, Chief Commercial Officer of Esperion Therapeutics. Glickman discusses the overall cholesterol-lowering space and how it’s planning to add a new therapeutic option for patients, what it means to establish a new therapy in a statin-dominated market, market research approaches, and more.
15m Oct 17, 2019
15m
Episode 41: The Patient Journey
Jeannine Lynch, senior director at BioMarin Pharmaceuticals, oversees patient access services and talks with editors about the patient journey in regard to receiving therapies, how to engage with patients more effectively, and where she sees the pharma industry in terms of patient engagement and patient centricity.
27m Oct 03, 2019
27m
Episode 40: Global Pharma Outlook
Janssen’s company group chairman of Europe, Middle East, and Africa operations, Kris Sterkens speaks with Pharm Exec editors. Kris talks about his finance background, global pricing issues, and challenges and opportunities for EMEA biopharma breaking into the US market.
31m Sep 19, 2019
31m
Episode 39: CEO Builds Business With Compassion
Apellis’ CEO and co-founder, Dr. Cedric Francois talks with editors about his unusual pharma journey, which has included research, clinical work, and the launch of two startups. Today, he’s here to share what he’s learned along the way and how he’s using that experience to improve lives.
26m Sep 05, 2019
26m
Episode 38: Customer-Centric Innovation
Christine Sakdalan, Head of Franchise Strategy and Customer Solutions at Janssen Pharmaceutical talks with Pharm Exec editors about how patient-centricity fuels innovation, the difference between patient and customer centricity, and educational programs that need to be implemented for patients, providers, and payers.
14m Aug 22, 2019
14m
Episode 37: Differentiating Yourself in Crowded Therapeutic Areas
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncology field, why he considers G1 Therapeutics an "old school company," and about the North Carolina biotech landscape.
21m Aug 08, 2019
21m
Episode 36: A View from the Editors' Desks
Pharm Exec editors share insights into what they've been working on this summer for the June, July, and August issues; plus a sneak peek into what's coming in September!
31m Jul 25, 2019
31m